Peter Bowers
About Peter Bowers
Education and Expertise in Biochemistry
Peter Bowers holds a PhD in biochemistry from the University of Washington in Seattle. In his academic career, he was a postdoctoral fellow in the laboratories of esteemed researchers David Baker and David Eisenberg. This background has provided him with specialized knowledge and a robust foundation in biochemistry, particularly relevant to the field of biotherapeutics.
Professional Role as Head of Biotherapeutics
Peter Bowers currently serves as the Head of Biotherapeutics. In this role, he directs various initiatives related to the development and optimization of therapeutic antibodies and other biopharmaceutical products. His leadership in this capacity is bolstered by extensive industry and academic experience.
Past Leadership at AnaptysBio Inc
Peter Bowers was a Senior Director and one of the scientific co-founders of AnaptysBio Inc. During his tenure, he oversaw the discovery and development of multiple first-in-class, clinical-stage antibodies. He directed over 50 pharmaceutical antibody therapeutic programs, driving significant advancements in the field of antibody therapeutics.
Academic Contributions at UCLA
Peter Bowers previously served as an Associate Professor and Director of the David Geffen School of Medicine Therapeutic Antibody Lab at UCLA. His work in this academic setting involved leading research initiatives, providing educational guidance, and contributing to significant advancements in therapeutic antibody discovery.
Research and Publications in Therapeutic Antibodies
Peter Bowers has authored more than 35 research papers and patents. His work focuses on therapeutic antibody discovery, mammalian display, somatic hypermutation for antibody discovery, protein engineering, and affinity maturation. These contributions have had a substantial impact on the field of biopharmaceutical research and development.